Sort by
Keyphrases
Mucosal Immunity
100%
HIV Patients
100%
Antiretroviral Therapy
100%
C-C Chemokine Receptor Type 5 (CCR5)
100%
Nave
100%
Pilot Randomized Controlled Trial
100%
Integrase Inhibitors
100%
CD8+ T
80%
Maraviroc
80%
T Cells
40%
HIV DNA
40%
Inflammatory Markers
40%
Duodenum
40%
Cell Density
40%
Soluble CD14 (sCD14)
40%
Zonulin-1
40%
Gut Tissue
20%
T Cell Subsets
20%
CD4+ T Cells
20%
Flow Cytometry
20%
Interleukin-6
20%
HLA-DR
20%
Mononuclear Cells
20%
Antiviral Drugs
20%
Memory CD8+ T Cells
20%
High-performance Liquid Chromatography
20%
Mucosal Immune Response
20%
CD4+
20%
Tenofovir Disoproxil Fumarate
20%
Combination Therapy
20%
HIV Persistence
20%
HIV RNA
20%
Tissue Concentration
20%
Plasma Concentration
20%
Patient-completed
20%
CD8+
20%
Gut-associated Lymphoid Tissue
20%
Cell Subsets
20%
Unique Effects
20%
Acid Soluble
20%
Efavirenz
20%
Immune Reconstitution
20%
Antiretroviral Therapy Regimens
20%
Cell Ratio
20%
Fixed-dose Combination
20%
CD38
20%
Intestinal Tissue
20%
HIV Control
20%
Class-dependent
20%
Therapy Treatment
20%
Tissue Penetration
20%
T-cell Markers
20%
Intestinal Biopsy
20%
CD4-CD8 Ratio
20%
Drug Distribution
20%
Duodenal Biopsy
20%
Rectal Biopsy
20%
Raltegravir
20%
Lipoteichoic Acid
20%
Viral Reservoir
20%
CD4%
20%
Liquid Chromatography-mass Spectroscopy
20%
MVCs
20%
CCR5 Inhibitors
20%
Quadruple Regimen
20%
Cell-associated HIV
20%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
CCR5
100%
Mucosal Immunity
100%
Integrase
100%
Cytotoxic T-Cell
50%
Blood Plasma
37%
T Cell
37%
T Cell Subset
25%
CD14
25%
Duodenum
25%
Cell Density
25%
CD4
12%
T-Helper Cell
12%
HLA-DR
12%
Mononuclear Cell
12%
High Performance Liquid Chromatography
12%
ELISA
12%
Interleukin 6
12%
CD8
12%
Cell Marker
12%
Immune Reconstitution
12%
CD38
12%
Gut-Associated Lymphoid Tissue
12%
CD4 CD8 Ratio
12%
Tenofovir
12%
Drug Distribution
12%
Lipoteichoic Acid
12%
Viral Reservoir
12%
Ribonucleic Acid
12%